Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Treasury Shares (2016 - 2026)

Rockwell Medical filings provide 10 years of Treasury Shares readings, the most recent being $891.0 for Q4 2025.

  • On a quarterly basis, Treasury Shares changed 0.0% to $891.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $891.0, a 0.0% change, with the full-year FY2025 number at $891.0, changed 0.0% from a year prior.
  • Treasury Shares hit $891.0 in Q4 2025 for Rockwell Medical, down from $1.2 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.2 million in Q2 2025 to a low of $891.0 in Q1 2023.
  • Median Treasury Shares over the past 5 years was $30202.0 (2021), compared with a mean of $206494.2.
  • The widest YoY moves for Treasury Shares: up 130838.27% in 2025, down 99.8% in 2025.
  • Rockwell Medical's Treasury Shares stood at $29289.0 in 2021, then soared by 326.78% to $125000.0 in 2022, then plummeted by 99.29% to $891.0 in 2023, then changed by 0.0% to $891.0 in 2024, then changed by 0.0% to $891.0 in 2025.
  • The last three reported values for Treasury Shares were $891.0 (Q4 2025), $1.2 million (Q3 2025), and $1.2 million (Q2 2025) per Business Quant data.